Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimetic

Cancer-selective viral replication and delivery of a therapeutic immunomodulating, cancer-selective killing cytokine (mda-7/IL-24) by means of a new Cancer Terminator Virus (CTV) combined with a small molecule BH3 mimetic holds promise for treating both primary and metastatic hormone refractory pros...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Sarkar, Siddik, Pradhan, Anjan, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, Pellecchia, Maurizio, Fisher, Paul B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2015
Konular:
Author's View
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839355/
https://ncbi.nlm.nih.gov/pubmed/27141334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1078059
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller